ArticleActa medica Lituanica2026
Ultrasound Elastography in Evaluation of Peripheral Pulmonary Lesions.
Article in Acta medica Lituanica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differentiating benign from malignant peripheral pulmonary lesions (PPLs) remains a clinical challenge, especially in resource-limited settings. While computed tomography is the standard imaging modality, it involves radiation exposure and often lacks specificity. Methods: In this prospective observational study, 42 patients with peripheral pulmonary lesions underwent transthoracic SWE prior to histopathological evaluation. Elastography values were compared between benign and malignant lesions. Statistical analysis included ROC curve assessment, logistic regression, and correlation with histopathological and microbiological outcomes. Results: Of the 42 patients, 64.3% had malignant and 35.7% had benign lesions. The mean SWE value for malignant lesions was significantly higher (6.82 ± 2.27 kPa) than for benign lesions (3.72 ± 2.23 kPa; Conclusion: Transthoracic SWE is a non-invasive, radiation free and promising tool for evaluating PPLs, offering good diagnostic accuracy in distinguishing malignant from benign lesions. It holds particular promise in settings where access to advanced imaging or biopsy is limited, and may assist in triaging patients for early tissue diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.